Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Sabine Charrier"'
Autor:
Aude Parcelier, Julien Buisset, Emilie Neveu, Bastien Kauffmann, Sandrine Fraboulet, Peggy Sanatine, Samia Martin, C?drick Rousseaux, Nadia Avenier, Sabine Charrier
Publikováno v:
Re:GEN Open, Vol 2, Iss 1, Pp 28-36 (2022)
Background: In the context of ex vivo gene therapy or chimeric antigen receptor T cell (CAR-T) cell therapy, vector copy number (VCN) analysis in transduced cells by lentiviral vectors enables the assessment of risk and therapeutic efficiency in pati
Externí odkaz:
https://doaj.org/article/1891b6ea0fe24f2fbad1c22dc45dcd7f
Autor:
Sabine Charrier, Chantal Lagresle-Peyrou, Valentina Poletti, Michael Rothe, Grégory Cédrone, Bernard Gjata, Fulvio Mavilio, Alain Fischer, Axel Schambach, Jean-Pierre de Villartay, Marina Cavazzana, Salima Hacein-Bey-Abina, Anne Galy
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 15, Iss , Pp 232-245 (2019)
Genetic deficiency of the nuclease DCLRE1C/Artemis causes radiosensitive severe combined immunodeficiency (RS-SCID) with lack of peripheral T and B cells and increased sensitivity to ionizing radiations. Gene therapy based on transplanting autologous
Externí odkaz:
https://doaj.org/article/3824403f1c8443e1b57c5921ed3b19ae
Autor:
Valentina Poletti, Fabrizia Urbinati, Sabine Charrier, Guillaume Corre, Roger P. Hollis, Beatriz Campo Fernandez, Samia Martin, Michael Rothe, Axel Schambach, Donald B. Kohn, Fulvio Mavilio
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 11, Iss , Pp 167-179 (2018)
Sickle cell disease (SCD) is caused by a mutation (E6V) in the hemoglobin (Hb) β-chain that induces polymerization of Hb tetramers, red blood cell deformation, ischemia, anemia, and multiple organ damage. Gene therapy is a potential alternative to h
Externí odkaz:
https://doaj.org/article/eb2c06bff7d64ce5a72279d990d278a9
Autor:
Valentina Poletti, Sabine Charrier, Guillaume Corre, Bernard Gjata, Alban Vignaud, Fang Zhang, Michael Rothe, Axel Schambach, H. Bobby Gaspar, Adrian J. Thrasher, Fulvio Mavilio
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 9, Iss , Pp 257-269 (2018)
X-linked severe combined immunodeficiency (SCID-X1) is caused by mutations in the interleukin-2 receptor γ chain gene (IL2RG), and it is characterized by profound defects in T, B, and natural killer (NK) cell functions. Transplantation of hematopoie
Externí odkaz:
https://doaj.org/article/5801774173f54a5ca585e79a225cd4e4
Autor:
Sabine Charrier, Michael Blundell, Gregory Cédrone, Fawzia Louache, William Vainchenker, Adrian J. Thrasher, Anne Galy
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
The Wiskott-Aldrich syndrome protein is an essential cytoskeleton regulator found in cells of the hematopoietic lineage and controls the motility of leukocytes. The impact of WAS gene deficiency on the mobilization of hematopoietic progenitor/stem ce
Externí odkaz:
https://doaj.org/article/cd49dbcf1c44494894b00ee0a08857c0
Autor:
Nicolas Vignier, Fatima Amor, Paul Fogel, Angélique Duvallet, Jérôme Poupiot, Sabine Charrier, Michel Arock, Marie Montus, Isabelle Nelson, Isabelle Richard, Lucie Carrier, Laurent Servais, Thomas Voit, Gisèle Bonne, David Israeli
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55281 (2013)
Biomarkers are critically important for disease diagnosis and monitoring. In particular, close monitoring of disease evolution is eminently required for the evaluation of therapeutic treatments. Classical monitoring methods in muscular dystrophies ar
Externí odkaz:
https://doaj.org/article/5331d55271d5433a82a47bf22aaec121
Autor:
Grégory Cédrone, Alain Fischer, Sabine Charrier, Axel Schambach, Michael Rothe, Chantal Lagresle-Peyrou, Bernard Gjata, Salima Hacein-Bey-Abina, Jean-Pierre de Villartay, Fulvio Mavilio, Anne Galy, Valentina Poletti, Marina Cavazzana
Publikováno v:
Mol Ther Methods Clin Dev
Mol Ther Methods Clin Dev, 2019, 15, pp.232-245. ⟨10.1016/j.omtm.2019.08.014⟩
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 15, Iss, Pp 232-245 (2019)
Mol Ther Methods Clin Dev, 2019, 15, pp.232-245. ⟨10.1016/j.omtm.2019.08.014⟩
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 15, Iss, Pp 232-245 (2019)
Genetic deficiency of the nuclease DCLRE1C/Artemis causes radiosensitive severe combined immunodeficiency (RS-SCID) with lack of peripheral T and B cells and increased sensitivity to ionizing radiations. Gene therapy based on transplanting autologous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95eb6abbec6734dd7e1265579a3a67bb
https://hal.archives-ouvertes.fr/hal-02880790
https://hal.archives-ouvertes.fr/hal-02880790
Autor:
Axel Schambach, Sabine Charrier, Uta Müller-Kuller, Ute Modlich, Michael Rothe, Bobby Gaspar, Christian Brendel, Manuel Grez, Adrian J. Thrasher, Anne Galy, Daniela Abriss, Hana Kunkel, Stefan Stein, Giorgia Santilli
Publikováno v:
Hum Gene Ther Clin Dev
Hum Gene Ther Clin Dev, 2018, 29, pp.69-79. ⟨10.1089/humc.2017.245⟩
Human gene therapy. Clinical development
Human gene therapy. Clinical development, 2018, 29 (2), pp.69-79. ⟨10.1089/humc.2017.245⟩
Hum Gene Ther Clin Dev, 2018, 29, pp.69-79. ⟨10.1089/humc.2017.245⟩
Human gene therapy. Clinical development
Human gene therapy. Clinical development, 2018, 29 (2), pp.69-79. ⟨10.1089/humc.2017.245⟩
International audience; Chronic granulomatous disease (CGD) is a debilitating primary immunodeficiency affecting phagocyte function due to the absence of nicotinamide dinucleotide phosphate (NADPH) oxidase activity. The vast majority of CGD patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef25248bf2b13c212f3150b10f5ad753
https://hal.archives-ouvertes.fr/hal-02880787
https://hal.archives-ouvertes.fr/hal-02880787
Autor:
Parinda A. Mehta, Julián Sevilla, Maria Roser Pujol, José A. Casado, Anne Galy, Sabine Charrier, María L. Lamana, Rebeca Sanchez-Dominguez, Cristina Díaz de Heredia, Jordi Surrallés, Rosa Yañez, Guillermo Guenechea, José C. Segovia, Susana Navarro, Juan A. Bueren, Paula Río
Publikováno v:
Blood
Blood, 2017, 130 (13), pp.1535-1542. ⟨10.1182/blood-2017-03-774174⟩
Blood, American Society of Hematology, 2017, 130 (13), pp.1535-1542. ⟨10.1182/blood-2017-03-774174⟩
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Blood, 2017, 130 (13), pp.1535-1542. ⟨10.1182/blood-2017-03-774174⟩
Blood, American Society of Hematology, 2017, 130 (13), pp.1535-1542. ⟨10.1182/blood-2017-03-774174⟩
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International audience; Previous Fanconi anemia (FA) gene therapy studies have failed to demonstrate engraftment of gene-corrected hematopoietic stem and progenitor cells (HSPCs) from FA patients, either after autologous transplantation or infusion i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cf37e2a2bf00b94877944883f51001b
https://hal.science/hal-02881013
https://hal.science/hal-02881013
Autor:
Paula, Río, Susana, Navarro, Guillermo, Guenechea, Rebeca, Sánchez-Domínguez, Maria Luisa, Lamana, Rosa, Yañez, Jose A, Casado, Parinda A, Mehta, Maria Roser, Pujol, Jordi, Surrallés, Sabine, Charrier, Anne, Galy, José C, Segovia, Cristina, Díaz de Heredia, Julián, Sevilla, Juan A, Bueren
Publikováno v:
Blood. 130(13)
Previous Fanconi anemia (FA) gene therapy studies have failed to demonstrate engraftment of gene-corrected hematopoietic stem and progenitor cells (HSPCs) from FA patients, either after autologous transplantation or infusion into immunodeficient mice